[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR9710544A - Composite treatment method and pharmaceutical composition - Google Patents

Composite treatment method and pharmaceutical composition

Info

Publication number
BR9710544A
BR9710544A BR9710544A BR9710544A BR9710544A BR 9710544 A BR9710544 A BR 9710544A BR 9710544 A BR9710544 A BR 9710544A BR 9710544 A BR9710544 A BR 9710544A BR 9710544 A BR9710544 A BR 9710544A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
treatment method
composite treatment
composite
pharmaceutical
Prior art date
Application number
BR9710544A
Other languages
Portuguese (pt)
Inventor
Argyrios Georgious Arvanitis
Robert John Chorvat
Paul Joseph Gilligan
Liqui He
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Priority claimed from US08/899,242 external-priority patent/US6124289A/en
Priority claimed from PCT/US1997/013072 external-priority patent/WO1998003510A1/en
Publication of BR9710544A publication Critical patent/BR9710544A/en

Links

BR9710544A 1996-07-24 1997-07-23 Composite treatment method and pharmaceutical composition BR9710544A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2329096P 1996-07-24 1996-07-24
US68604796A 1996-07-24 1996-07-24
US08/899,242 US6124289A (en) 1996-07-24 1997-07-23 Azolo triazines and pyrimidines
PCT/US1997/013072 WO1998003510A1 (en) 1996-07-24 1997-07-23 Azolo triazines and pyrimidines

Publications (1)

Publication Number Publication Date
BR9710544A true BR9710544A (en) 1999-08-17

Family

ID=27362048

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710544A BR9710544A (en) 1996-07-24 1997-07-23 Composite treatment method and pharmaceutical composition

Country Status (15)

Country Link
JP (2) JP4704521B2 (en)
CN (3) CN1104432C (en)
AR (1) AR049583A2 (en)
BR (1) BR9710544A (en)
CA (1) CA2259583C (en)
CZ (1) CZ299451B6 (en)
EA (1) EA004403B1 (en)
EE (1) EE04316B1 (en)
HR (1) HRP970413A2 (en)
IL (4) IL127871A0 (en)
NO (1) NO315610B1 (en)
NZ (1) NZ333777A (en)
PL (1) PL195762B1 (en)
SI (1) SI9720045B (en)
SK (1) SK286461B6 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2440553C (en) * 2001-03-13 2010-06-08 Paul J. Gilligan 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
WO2004110454A1 (en) * 2003-06-13 2004-12-23 Ishihara Sangyo Kaisha, Ltd. COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
US7329662B2 (en) * 2003-10-03 2008-02-12 Hoffmann-La Roche Inc. Pyrazolo-pyridine
GB0519957D0 (en) * 2005-09-30 2005-11-09 Sb Pharmco Inc Chemical compound
PL2094709T3 (en) * 2006-09-20 2011-02-28 Lilly Co Eli Thiazole pyrazolopyrimidines as crf1 receptor antagonists
CN103694242B (en) * 2013-12-10 2016-01-06 昆明翔昊科技有限公司 Pyrazolopyrimidines and pharmaceutical composition thereof and its application in pharmacy
BR112020002967A2 (en) 2017-08-14 2020-08-11 Spruce Biosciences, Inc. corticotropin releasing factor receptor antagonists
CN112500416B (en) * 2019-07-30 2021-12-17 厦门宝太生物科技股份有限公司 Preparation method of pyrazolotriazine compound intermediate
BR112023002497A2 (en) 2020-08-12 2023-05-02 Spruce Biosciences Inc METHODS AND COMPOSITIONS FOR TREATMENT OF POLYCYSTIC OVARIAN SYNDROME
US11708372B2 (en) 2021-11-19 2023-07-25 Spruce Biosciences, Inc. Crystalline composition of tildacerfont and methods of use and preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995039A (en) * 1975-05-27 1976-11-30 Merck & Co., Inc. Pyrazolo [1,5-a] [1,3,5] triazines
JPS6157587A (en) * 1984-08-29 1986-03-24 Shionogi & Co Ltd Condensed heterocyclic derivative and antiulcerative
US4824834A (en) * 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds
JP2691317B2 (en) * 1989-08-25 1997-12-17 株式会社大塚製薬工場 4-Hydroxy-8- (3-lower alkoxy-4-phenylsulfinylphenyl) pyrazolo [1,5-a] -1,3,5-triazine optically active salts and process for producing the same
EP0503099A4 (en) * 1990-10-09 1993-12-01 Otsuka Pharmaceutical Co., Ltd. Pyrimidine derivative, production thereof, and androgen inhibitor
CA2107479C (en) * 1991-04-22 1997-12-16 Makoto Inoue Pyrazolo[1,5-a]pyrimidine derivatives and anti-inflammatory agent containing the same
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

Also Published As

Publication number Publication date
NZ333777A (en) 2000-07-28
CZ299451B6 (en) 2008-07-30
EA004403B1 (en) 2004-04-29
PL195762B1 (en) 2007-10-31
SK9799A3 (en) 2005-04-01
EE9900019A (en) 1999-08-16
IL164513A (en) 2010-04-29
CN1225637A (en) 1999-08-11
IL164513A0 (en) 2005-12-18
JP4704521B2 (en) 2011-06-15
PL331523A1 (en) 1999-07-19
AR049583A2 (en) 2006-08-16
CA2259583C (en) 2009-11-17
NO315610B3 (en) 2003-09-29
SI9720045B (en) 2008-02-29
HRP970413A2 (en) 1998-10-31
EE04316B1 (en) 2004-06-15
CN1104432C (en) 2003-04-02
CN1250223C (en) 2006-04-12
IL127871A (en) 2010-04-29
SI9720045A (en) 1999-10-31
NO315610B1 (en) 2003-09-29
NO990264D0 (en) 1999-01-21
IL150163A (en) 2010-12-30
JP4194539B2 (en) 2008-12-10
EA199900158A1 (en) 1999-10-28
SK286461B6 (en) 2008-10-07
IL127871A0 (en) 1999-10-28
CA2259583A1 (en) 1998-01-29
CZ18499A3 (en) 1999-11-17
CN1327793A (en) 2001-12-26
JP2002513382A (en) 2002-05-08
CN1388126A (en) 2003-01-01
JP2005097257A (en) 2005-04-14
NO990264L (en) 1999-03-10

Similar Documents

Publication Publication Date Title
BR9407799A (en) Composition of matter treatment method and pharmaceutical composition
BR9609132A (en) Seed composition and treatment method
DE69737795D1 (en) COMPOSITE COMPONENT AND WALL CONSTRUCTION PROCESS
DE69607321D1 (en) CLEANING PROCEDURE AND COMPOSITION
EE9800234A (en) Method of treatment and pharmaceutical composition
EE200000226A (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
BR9710379A (en) Decorative titanium material and hardening method for the same
BR9509688A (en) Pharmaceutical composition and composition
BR9710544A (en) Composite treatment method and pharmaceutical composition
EE9800164A (en) Pharmaceutical composition and method for treating epithelioma
DE69718502D1 (en) DENTAL COMPOSITION, SYSTEM AND METHOD
PT932400E (en) DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN
BR9700362A (en) Intermediate cylinder set of srlo and conveyor system
FR2746261B1 (en) INSECTICIDE COMPOSITION AND PREPARATION METHOD
BR9707332A (en) Double curing coating method and formulation
ID18698A (en) PHARMACEUTICAL COMPOSITION
ID19437A (en) PROCESSING AND COMPOSITION FOR ANTI-PARASIT TREATMENT AROUND ANIMAL PLACES
BR9612503A (en) Self-initialized encoder and method
DE69524527D1 (en) AIDS-inhibiting drug preparation and method
BR9610382A (en) Cableo treatment composition
GB9606579D0 (en) Pharmaceutical composition and methods for the manufacture thereof
EE9500029A (en) Pharmaceutical spray composition and method for its preparation
ID16924A (en) POLYLELEFIN TREATMENT METHOD
EE200000074A (en) Method and equipment for waste treatment
FI962282A (en) Arrangement and method for calling

Legal Events

Date Code Title Description
TE Change of address
B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO ATENDE AOS ARTIGOS 24 E 25 DA LEI 9.279/96

B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]